Texas Appeals Court Nixes $10M Award Against Fen-Phen Atty

Law360, Houston (February 28, 2013, 4:58 PM EST) -- A Texas appeals court said Thursday that faulty testimony led it to toss a jury’s verdict that had resulted in awards exceeding $10 million to 600 former clients who said a personal injury attorney had overcharged them in litigation against a Pfizer Inc. unit over the diet drug fen-phen.

The Fourteenth District Court of Appeals ruled that testimony of a legal ethics expert in a test case against attorney George Fleming “crossed the border of admissibility." 

Lillian Hardwick testified that the Fleming had violated state disciplinary...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.